Compass Therapeutics, Inc. (CMPX) stock
CMPXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.83−0.01 (-0.93%)
Close on Nov 11, 2026Market cap $149.51MP/E –Yield –
Compass Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Compass Therapeutics's enterprise value was -$30.37M on Nov 11, 2026, against $810.02M a year earlier. Over the last 5 years it ranged from -$38.48M to $916.57M, with a median of $145.64M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$30.37M | -104.1% |
| 2025 | Dec 31, 2025 | $733.67M | +800.2% |
| 2024 | Dec 31, 2024 | $81.50M | +132.1% |
| 2023 | Dec 29, 2023 | $35.11M | -90.9% |
| 2022 | Dec 30, 2022 | $387.59M | +122.7% |
| 2021 | Dec 31, 2021 | $174.01M | – |
See a number that looks wrong?